Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

VolitionRX Limited Common Stock (NY:VNRX)

0.7500 +0.0200 (+2.74%)
Official Closing Price Updated: 8:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about VolitionRX Limited Common Stock

< Previous 1 2 3 4 Next >
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. 
Via Benzinga
Why VolitionRX Stock Is Nosediving Friday
VolitionRX Ltd (NASDAQ: VNRX) shares are trading lower by 13.24% to $1.77 Friday morning after the company announced pricing of a 4.3 million share common stock offering at $1.75 per share. What Else? 
Via Benzinga
Is the Stock Market Open on Presidents’ Day 2023?
Investors are wondering if the stock market is open on Presidents' Day 2023 as they make weekend plans and we have the answer. 
Via InvestorPlace
VolitionRX's Return On Capital Employed Insights
 
Via Benzinga
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
Why Is Ambrx Biopharma (AMAM) Stock Down 15% Today?
Ambrx Biopharma (AMAM) stock is falling on Friday but it's not due to any negative news released by the medical company today. 
Via InvestorPlace
Why Is VolitionRX (VNRX) Stock Down 17% Today?
VolitionRX (VNRX) stock is taking a beating on Friday after the company revealed a proposed public offering for its shares. 
Via InvestorPlace
Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket
Gainers Ibio Inc (NYSE: IBIO) shares rose 162.6% to $1.97 in pre-market trading after dropping around 12% on Thursday. JMP Securities, on Thursday, downgraded iBio from Market Outperform to Market... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday! 
Via InvestorPlace
Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences
Via ACCESSWIRE
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
 
Via Benzinga
Sidoti's January Micro-Cap Conference
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
 
Via Benzinga
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million... 
Via Benzinga
Xenetic Biosciences, Inc. Announces Signing of Patent Assignment Related to Collaboration With VolitionRx Limited and CLS Therapeutics
Via ACCESSWIRE
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 456 stocks hit new 52-week lows. 
Via Benzinga
Sidoti's August Micro-Cap Virtual Conference
Via ACCESSWIRE
Around $1.1 Million Bet On Ring Energy? Check Out These 3 Penny Stocks Insiders Are Buying
U.S. crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer
Via ACCESSWIRE
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... 
Via Benzinga
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders. 
Via Benzinga
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading. 
Via Benzinga
Looking Into VolitionRX's Return On Capital Employed
According to data from Benzinga Pro, during Q1, VolitionRX's (AMEX:VNRX) reported sales totaled $114.21 thousand. Despite a 4.81% increase in earnings, the company posted a loss of $7.72 million. 
Via Benzinga
Recap: VolitionRX Q1 Earnings
VolitionRX (AMEX:VNRX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings VolitionRX missed estimated earnings... 
Via Benzinga
A Preview Of VolitionRX's Earnings
VolitionRX (AMEX:VNRX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that VolitionRX will... 
Via Benzinga
VolitionRX Earnings Perspective: Return On Capital Employed
Benzinga Pro data, VolitionRX (AMEX:VNRX) reported Q4 sales of $14.24 thousand. Earnings fell to a loss of $8.11 million, resulting in a 12.9% decrease from last quarter. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.